Hib IgG persistence following early booster dose [3]

Archives of Disease in Childhood

Volumn 90, Issue 3, 2005, Pages 329-

  Slack, M H ^a   Thwaites, R J ^a   Schapira, D ^b   Crowley Luke, A ^c   Southern, J ^d   Miller, E ^d   Goldblatt, D ^e  

^a ST MARY S HOSPITAL   (United Kingdom)

^b ROYAL HAMPSHIRE COUNTY HOSPITAL   (United Kingdom)

^c HPA Porton Down   (United Kingdom)

^d HPA Communic Dis Survlnc Centre   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; IMMUNOGLOBULIN G;

DRUG DOSE REGIMEN; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL MEMORY; LETTER; PRIORITY JOURNAL;

DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G;

EID: 14844303404     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2004.051599     Document Type: Letter

References (3)

1. Slack MH, Schapira D, Thwaites RJ, et al. Immune response of preterm infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines. J Infect Dis 2001;184:1617-20.
2. McVernon J, Andrews N, Slack MP, et al. Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet 2003;361:1521-3.
3. Slack MH, Schapira D, Thwaites RJ, et al. Responses to a fourth dose of Haemophilus influenzae type B conjugate vaccine in early life. Arch Dis Child Fetal Neonatal Ed 2004;89:F269-71.